Review Article
Dispersive Solid Phase Extraction for the Analysis of Veterinary Drugs Applied to Food Samples: A Review
Table 2
Magnetic sorbents applied to dispersive techniques in the analysis of veterinary drugs.
| Analyte | Matrix | Magnetic material coating | Eluent | Mode | Technique | Limit of detection | Recovery | Reference |
| Bisphenol A | Milk | Magnetic NPs-nylon 6 composite | MeOH | DMSPE | HPLC-UV | 3.05 μg L−1 | 86.0–99.0% | [33] |
| BZD | Swine tissue | Distillation-precipitation polymerization/Fe3O4/SiO2/poly(MAA-co-EGDMA) composite (mixture of MPS-modified, Fe3O4/SiO2, MAA, EGDMA, AIBN) | CAN-TFA | MSPE | CZE-UV | 1.05–10.42 ng g−1 (muscle) 1.06–12.61 ng g−1 (liver) | 81.1–105.4% | [32] |
| Estrogens | Meat (pork) | Magnetic nanoparticles (MNPs)/synthesis of CTAB-coated Fe3O4@caprylic acid NPs | MeOH | DMSPE | HPLC-DAD | 0.02–0.03 ng mL−1 | 93.3–106.7% | [35] |
| NSAIDs | Milk, human urine, and water | Magnetic ethylenediamine-functionalized graphene oxide nanocomposite | MeOH | UAMDSPME | HPLC-DAD | 0.03–0.1 ng mL−1 | 86.4–109.9% | [26] |
| NSAIDs | Urinary | 2-Aminobenzothiazole was polymerized on Fe3O4, graphene oxide/Fe3O4, graphene/Fe3O4 | Methanol/acetonitrile | MSPE | HPLC-DAD | 0.07–0.3 µg L−1 | 85.5–90.5% | [78] |
| QNs | Milk | Emulsion polymerization magnetic octyl-phenyl silica (TMOS and PTMS-C8 at different molar ratios) | MeOH-NaOH | MSPE | CE-UV | 9.0–12.0 μg L−1 | 74.0–98.0% | [30] |
| SAs | Milk | Distillation-precipitation polymerization/Fe3O4/SiO2/poly(MAA-co-EGDMA) composite (mixture of MPS-modified, Fe3O4/SiO2, MAA, EGDMA, AIBN, ACN) | Acetone-5% ammonia | MSPE | LC-MS/MS | 0.5–49.5 ng L−1 | 87.6–115.6% | [36] |
| SAs | Milk | Emulsion polymerization magnetic phenyl silica (PTMS and TMOS at different molar ratios) | MeOH-NaOH | MSPE | HPLC-DAD | 7.0–14.0 μg L−1 | 81.8–114.9%, | [60] |
| SAs | Milk | Presynthesized Fe3O4 nanoparticles (NPs) onto HCP/(HCP/Fe3O4) | ACN | MSPE | HPLC-DAD | 2.0–2.5 ng mL−1 | 84.0–105.0% | [85] |
| TCs | Milk | Emulsion polymerization magnetic phenyl silica (PTMS and TMOS at different molar ratios) | MeOH-acetic acid | MSPE | CE-DAD | 2.0–9.0 μg L−1 | 94.2–99.8% | [31] |
|
|
ACN: acetonitrile; AIBM: azo(bis)-isobutyronitrile; BZD: benzimidazole; CE: capillary electrophoresis; C8: octyltrimethoxysilane; CTAB: cetyltrimethylammonium bromide; DAD: diode array detector; DMSPE: dispersive micro-solid phase extraction; EGDMA: ethylene glycol dimethacrylate; HCP: hypercross-linked polystyrene; HPLC: high performance liquid chromatography; MAA; methacrylic acid; MeOH: methanol; MSPE: magnetic solid-phase extraction; NaOH: hydroxide sodium: NSAIDs: nonsteroidal anti-inflammatory drugs; QNs: quinolones; PTMS: phenyltrimethylsilane; SAs: sulfonamides; TCs: tetracyclines; TFA: trifluoroacetic acid; TMOS: tetramethyl orthosilicate; UAMDSPME: ultrasound-assisted magnetic dispersive solid-phase microextraction; UV: ultraviolet visible.
|